Marcia Cruz Correa, MD
Gastroenterology · San Juan, PRNPI 1962497164
Payments from drug & device makers
Across 2,464 payments — averaging $5036.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3M
- E.r. Squibb & Sons, L.L.C.$2.8M
- Janssen Research & Development, LLC$2.1M
- Merck$1.8M
- Mirati Therapeutics, Inc.$919K
- Incyte Corporation$646K
- plus $1.2M from 27 others
Across 4 payments — averaging $2451.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$10K
- AbbVie$40
What the payments were for
- Consulting fees$49,81380%
- Travel & lodging$10,62617%
- Food & beverage$1,8303%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1,227 | $2,953,499 |
| E.r. Squibb & Sons, L.L.C. | 40 | $2,835,292 |
| Janssen Research & Development, LLC | 329 | $2,099,349 |
| Merck | 122 | $1,753,034 |
| Mirati Therapeutics, Inc. | 95 | $918,619 |
| Incyte Corporation | 281 | $645,849 |
| Genentech, Inc. | 43 | $296,252 |
| Institut DE Recherches Internationales Servier | 91 | $243,402 |
| Seagen Inc. | 52 | $179,070 |
| Beigene, Ltd. | 53 | $148,081 |
| Amgen | 6 | $80,267 |
| Beone Medicines USA, Inc. | 25 | $62,735 |
| Pfizer | 19 | $52,273 |
| QED Therapeutics, Inc. | 12 | $48,486 |
| Eli Lilly Export S.A. Puerto Rico Branch | 3 | $38,656 |
| Servier Bioinnovation | 24 | $29,217 |
| Regeneron | 5 | $12,178 |
| Genmab U.S., Inc. | 5 | $5,323 |
| Beigene USA, Inc. | 3 | $2,426 |
| Exact Sciences | 4 | $2,275 |
| Institut DE Recherches Servier | 4 | $932 |
| AstraZeneca | 3 | $849 |
| Macrogenics, Inc. | 2 | $141 |
| Johnson & Johnson | 4 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $120 |
| Johnson And Johnson International | 1 | $101 |
| Smith+Nephew | 2 | $100 |
| Exelixis Inc. | 1 | $100 |
| Olympus Latin America, Inc. | 1 | $99 |
| Taiho Oncology, Inc. | 1 | $62 |
| Verity Pharmaceuticals Inc. | 2 | $42 |
| PBG Puerto Rico LLC | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,409,028 in reported general payments places this provider in the 95th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 28 | $240 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Juan
- Jose Rivera-AcostaSan Juan$882K
- Esther TorresSan Juan$493K
- Melvyn AcostaSan Juan$358K
- Melvin Melendez RiosSan Juan$129K
- Loscar SantiagoSan Juan$65K
- Henry Gonzalez RiveraSan Juan$34K
- Jose Munoz AcabaSan Juan$28K
- Hector LozanoSan Juan$28K
- Doris ToroSan Juan$25K
- Rafael Rodriguez LopezSan Juan$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.